Location History:
- Princeton, NJ (US) (2009)
- New York City, NY (US) (2016)
Company Filing History:
Years Active: 2009-2016
Title: Innovator Spotlight: Aliya Omer from Princeton, NJ
Introduction: Aliya Omer, a talented inventor based in Princeton, NJ, has made significant contributions to the field of therapeutic devices with her innovative inventions. With a total of three patents to her name, Aliya focuses on enhancing human health through electrical stimulation and galvanic treatments.
Latest Patents: Among her notable inventions, Aliya's latest patents include an "Electrical Stimulation Device with Additional Sensory Modalities" and a "Method of Treating Acne and Rosacea with Galvanic Generated Electricity." The first invention comprises a therapeutic apparatus that integrates an electrical stimulation delivery device along with a secondary modality delivery device, optimizing therapy during designated refractory periods. The second patent outlines a focused method for treating acne and rosacea by applying electricity to the skin, utilizing specific conductive electrodes to achieve effective treatment results.
Career Highlights: Aliya has worked with prominent companies such as Johnson & Johnson Consumer Companies, Inc. and Johnson & Johnson Consumer Inc., where she further honed her skills and expertise in product development and innovation. Her work experience at these leading organizations signifies her commitment to creating impactful health solutions.
Collaborations: Throughout her career, Aliya has collaborated with skilled professionals like Ying Sun and Jeffrey M. Wu, leveraging their collective knowledge to drive her innovative projects forward. These collaborations have enriched her work and contributed to the success of her inventions.
Conclusion: Aliya Omer stands out as a remarkable inventor whose work is paving the way for new therapeutic approaches. With her dedication to innovation and health, she continues to inspire others in the field. As she advances her inventions, the potential for her contributions to the healthcare industry remains substantial.